CHRN ChronoScale Corp.

Price (delayed)

$25.43

Market cap

$90.62M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.38

Enterprise value

$90.94M

?
Relative Growth: Rel. Growth: 18
Relative Strength: Rel. Strength: 99
Relative Valuation: Rel. Valuation: 10
Relative Profitability: Rel. Profitability: 13

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, ...

Highlights
The debt is down by 23% YoY and by 7% QoQ
CHRN's EPS is up by 27% year-on-year but it is down by 10% since the previous quarter
ChronoScale's equity has shrunk by 84% YoY and by 77% QoQ
CHRN's quick ratio is down by 45% YoY and by 4.1% QoQ

Key stats

What are the main financial stats of CHRN

CHRN stock price

How has the ChronoScale stock price performed over time
Intraday
-0.93%
1 week
32.93%
1 month
64.22%
1 year
801.77%
YTD
194.33%
QTD
138.78%

Financial performance

How have ChronoScale's revenue and profit performed over time
Revenue
$11.57M
Gross profit
$6.11M
Operating income
-$15.5M
Net income
-$15.69M
Gross margin
52.9%
Net margin
-135.7%
The net margin has shrunk by 121% YoY and by 48% QoQ
CHRN's operating margin has shrunk by 121% YoY and by 29% QoQ
CHRN's operating income is down by 46% year-on-year and by 16% since the previous quarter
The net income has contracted by 45% YoY and by 34% from the previous quarter

Price vs fundamentals

How does CHRN's price correlate with its fundamentals

Growth

What is ChronoScale's growth rate over time

Valuation

What is ChronoScale stock price valuation
P/E
N/A
P/B
43.36
P/S
7.83
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.86
CHRN's EPS is up by 27% year-on-year but it is down by 10% since the previous quarter
ChronoScale's equity has shrunk by 84% YoY and by 77% QoQ
ChronoScale's revenue has decreased by 34% YoY and by 10% from the previous quarter

Efficiency

How efficient is ChronoScale business performance
The ROE has plunged by 140% YoY and by 79% from the previous quarter
CHRN's return on sales has dropped by 121% year-on-year and by 49% since the previous quarter
The ROIC has plunged by 97% YoY and by 50% from the previous quarter
The ROA has plunged by 89% YoY and by 46% from the previous quarter

Dividends

What is CHRN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CHRN.

Financial health

How did ChronoScale financials performed over time
ChronoScale's total assets is 41% more than its total liabilities
CHRN's quick ratio is down by 45% YoY and by 4.1% QoQ
The current ratio has declined by 34% year-on-year and by 4.9% since the previous quarter
The debt is 107% higher than the equity
ChronoScale's equity has shrunk by 84% YoY and by 77% QoQ
The debt is down by 23% YoY and by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.